Patients diagnosed with PCL(s ) who underwent pancreatic surgery in one of the participant centers. Surgical indication must adhere to at least one of current guidelines on PCLs management (6), based on clinical, biochemical, and radiological (MR and/or EUS) features.
Pancreatic surgery B83performed for supposed increased risk of cyst(s) malignant degeneration following current guidelines on PCLs management (6).
Absence of clinical, biochemical, radiological, and anatomopathological evidence of pancreatic cancer at pancreatic surgery.
Non-opposition to the anonymous data processing by the included patients.
You may not be if
Patients presenting with evidence of pancreatic cancer at surgery.
PCL(s) diagnosis and treatment performed without one between EUS and pancreatic MR. surgery performed in the absence of the criteria proposed by current guidelines.
Unavailability of both preoperative EUS and pancreatic MR data.
Unavailability of postoperative PCL(s) anatomopathological analysis results.
SBO diagnosis performed without CT-scan.
Clareo Health | Predicting Cancer in Pancreatic Cystic Lesions Through Artificial Intelligence
